Ryohei Ohtani

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Journal: Cephalalgia : an international journal of headache

Published: March 26, 2026

Biologic therapy and brain atrophy in neuromyelitis optica: a Japanese-German longitudinal MRI study.

Biologic therapy and brain atrophy in neuromyelitis optica: a Japanese-German longitudinal MRI study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 30, 2025

Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease.

Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 24, 2024

Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients.

Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 20, 2023

Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.

Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.

Journal: Journal of diabetes investigation

Published: June 10, 2023

Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.

Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.

Journal: Scientific reports

Published: April 02, 2023

Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD.

Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD.

Journal: Scientific reports

Published: December 15, 2022

Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders.

Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders.

Journal: Journal of neurology

Published: June 16, 2021

AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.

AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: May 21, 2021

Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.

Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 15, 2021

Cryptococcal Meningitis in a Fingolimod-Treated Patient: Positive Antigen Test a Year Before Onset.

Cryptococcal Meningitis in a Fingolimod-Treated Patient: Positive Antigen Test a Year Before Onset.

Journal: Neurology. Clinical practice

Published: July 27, 2020

Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.

Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: June 28, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026